FDA Approves Pomalidomide for Advanced Multiple Myeloma

Pomalidomide has been approved for the treatment of patients with multiple myeloma whose disease has progressed after treatment with at least two prior therapies, including lenalidomide and bortezomib,...
Source: OncologySTAT Latest News - Category: Cancer & Oncology Source Type: news